Company Data
Inhibitor Therapeutics Inc
Ticker
INTI
Current Price
$0.075 -6.25%
Market Cap
$12.9M
Price Target
Refer to Report
Volume
10.3K
52wk Range
$0.0338 - $0.0899
Overview
Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company’s main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.